How to Buy Soleno Therapeutics Stock
Soleno Therapeutics Inc
Soleno Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Soleno Therapeutics stock last closed at $71.40, up 3.58% from the previous day, and has increased 90.2% in one year. It has overperformed other stocks in the Biotechnology industry by 1.67 percentage points. Soleno Therapeutics stock is currently +93.34% from its 52-week low of $36.93, and -3.51% from its 52-week high of $74.00.
As of Apr 22, 2025, there are 45.86M SLNO shares outstanding. The market value of SLNO is $3.27B. In the last 24 hours, 1.04M SLNO shares were traded.
How to Buy Soleno Therapeutics Stock
Not sure how to invest in Soleno Therapeutics stock? Here's how.
- Figure out where to buy Soleno Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Soleno Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Pick your method of payment and add your details.
- Analyze Soleno Therapeutics stock: The Soleno Therapeutics ticker symbol is SLNO. Is Soleno Therapeutics stock a good investment? Should you buy shares of SLNO? How do SLNO's underlying business fundamentals look? Do top analysts think Soleno Therapeutics is a good buy? Why has SLNO's stock price moved recently? (Hint: Our stock market analysis website can help you understand if SLNO is a good stock to buy).
- Execute your SLNO buy order: Decide if you will purchase SLNO shares at the current market price or use a limit order to buy SLNO shares at a particular price.
- Monitor your SLNO position: Create a watchlist to get the latest news on your position in Soleno Therapeutics shares.
Step 1: Figure out where to buy Soleno Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy SLNO stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you can invest in SLNO today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new trading account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've opened your account on the best stock market app for beginners, your next step is to transfer the money for your investment:
Check out the video below if you need help depositing money into your investment account.
Step 4: Analyze Soleno Therapeutics stock
After you have identified the best place to buy Soleno Therapeutics stock, it's absolutely critical to analyze their stock prior to investing, so you truly understand the risk as well as the upside.
Soleno Therapeutics stock data
Soleno Therapeutics Due Diligence Checks
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on SLNO's stock page.
Is SLNO stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SLNO's true value.
Using relative valuations ratios:
- SLNO could be overvalued based on its P/B ratio of 13.36x, relative to Biotechnology industry P/B ratio of 4.16x
You can access more valuation analysis on SLNO's stock here.
How do SLNO Financials look?
Passed Health Checks:
- SLNO has $291.44M in cash and short term investments. This is sufficient to cover its annual cash burn of $69.31M.
- Total SLNO debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the SLNO balance sheet.
- SLNO has a low debt to equity ratio of 0.35.
- There are more short-term assets than long-term liabilities on the SLNO balance sheet.
- SLNO has cash burn of 69314000. It has sufficient cash and short-term investments to cover this for at least one year.
Do analysts think it's a good time to buy SLNO stock
Out of 7 sell side analysts who monitor SLNO, the consensus analyst rating on SLNO is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest SLNO Analyst Forecasts
Kristen Kluska, a top 2% analyst from Cantor Fitzgerald maintains SLNO with a strong buy rating and raises their SLNO price target from $67.00 to $123.00, on Mar 27, 2025.
Cantor Fitzgerald's Kristen Kluska raised their price target on Soleno Therapeutics (NASDAQ: SLNO) by 83.6% from $67 to $123 on 2025/03/27. The analyst maintained their Strong Buy rating on the stock.
Kluska said they raised their price target after Soleno Therapeutics announced the FDA's approval of VYKAT XR for the treatment of hyperphagia in patients over 4 years old with Prader-Willi Syndrome.
"The full label was in line with expectations, reflecting a best-case scenario," the analyst detailed, noting that the stock price was up "meaningfully" on the news.
Leland Gershell, a top 5% analyst from Oppenheimer maintains SLNO with a buy rating and raises their SLNO price target from $65.00 to $73.00, on Oct 28, 2024.
You can dive deeper into what analysts are forecasting on the Soleno Therapeutics stock forecast page.
Metrics for Advanced SLNO Traders
Who is buying/selling SLNO?
In the last 12 months, executives and large shareholders at SLNO have sold more shares than they have bought.
Patricia C. Hirano, Officer title Senior Vice President Regulatory Affairs of SLNO, was the latest SLNO insider to sell. They sold $265,156.02 worth of SLNO stock on Apr 1, 2025.
Research more about who owns SLNO stock here.
Can I get consistent income from SLNO stock?
No, Soleno Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about SLNO
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your SLNO buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, use a limit order.
Hit the Open Trade button and eToro will execute your order.
If you need more help with investing in stocks on eToro, click the helpful video below:
Step 6: Monitor your SLNO position
Now that you own some SLNO shares, you'll want to keep up with your shares.
Create a watchlist to get alerted to the latest events about your SLNO stock.
SLNO Feed
How to Buy Stock in Soleno Therapeutics
To summarize, here are the 6 steps for buying Soleno Therapeutics stock:
- Figure out where to buy Soleno Therapeutics stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Analyze Soleno Therapeutics stock
- Execute your SLNO buy order
- Monitor your SLNO position
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep an eye on your investment in Soleno Therapeutics, hit the button below to create your watchlist.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.